Publications by authors named "Mario Salvi"

Claim this Profile
S
Successful outcome of Rituximab treatment based on lymphocyte immunophenotyping in active Thyroid Eye Disease: a case report.
Mirco Armenti, Sara Maioli, Chiara Riva, Nicola Currò, Giorgia Moschetti, Mario Salvi

Thyroid Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alemtuzumab-induced thyroid eye disease successfully treated with a single low dose of rituximab.
Ilaria Muller, Sara Maioli, Mirco Armenti, Laura Porcaro, Nicola Currò, Mario Salvi

Eur Thyroid J· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Letter to the Editor From Lui et al: "Increased Risk of Thyroid Eye Disease Following COVID-19 Vaccination".
Ilaria Muller, Dario Consonni, Erica Crivicich, Francesco Di Marco, Nicola Currò, Mario Salvi

J Clin Endocrinol Metab· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presentation of Graves' orbitopathy within European Group On Graves' Orbitopathy (EUGOGO) centres from 2012 to 2019 (PREGO III).
Anna Schuh, Goksun Ayvaz, Lelio Baldeschi, Maja Baretić, Dorte Bechtold, Mario Salvi

Br J Ophthalmol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased Risk of Thyroid Eye Disease Following Covid-19 Vaccination.
Ilaria Muller, Dario Consonni, Erica Crivicich, Francesco Di Marco, Nicola Currò, Mario Salvi

J Clin Endocrinol Metab· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-COV-2 specific t-cells in patients with thyroid disorders related to COVID-19 are enriched in the thyroid and acquire a tissue-resident memory phenotype.
Ylenia Silvestri, Francesca Clemente, Giorgia Moschetti, Sara Maioli, Elena Carelli, Mario Salvi

Clin Immunol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gut Microbiome Associated With Graves Disease and Graves Orbitopathy: The INDIGO Multicenter European Study.
Filippo Biscarini, Giulia Masetti, Ilaria Muller, Hedda Luise Verhasselt, Danila Covelli, Mario Salvi

J Clin Endocrinol Metab· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Visual Outcomes of Dysthyroid Optic Neuropathy After Surgical Orbital Decompression.
Nicola Currò, Claudio Guastella, Giacinta Pirola, Barbara Calonghi, Alessandra Bottari de Castello, Mario Salvi

Thyroid· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcome of thyroid abnormalities in patients with severe Covid-19.
Ilaria Muller, Anita Daturi, Matteo Varallo, Tiziana E Re, Davide Dazzi, Mario Salvi

Eur Thyroid J· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of thyroid eye disease: a Consensus Statement by the American Thyroid Association and the European Thyroid Association.
Henry B Burch, Petros Perros, Tomasz Bednarczuk, David S Cooper, Peter J Dolman, Mario Salvi

Eur Thyroid J· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Thyroid Eye Disease: A Consensus Statement by the American Thyroid Association and the European Thyroid Association.
Henry B Burch, Petros Perros, Tomasz Bednarczuk, David S Cooper, Peter J Dolman, Mario Salvi

Thyroid· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microbiota Alterations in Patients with Autoimmune Thyroid Diseases: A Systematic Review.
Nadia Sawicka-Gutaj, Dawid Gruszczyński, Natalia Zawalna, Kacper Nijakowski, Ilaria Muller, Mario Salvi

Int J Mol Sci· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Future Projections in Thyroid Eye Disease.
Giuseppe Barbesino, Mario Salvi, Suzanne K Freitag

J Clin Endocrinol Metab· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment: OPTIC-X Study.
Raymond S Douglas, George J Kahaly, Shoaib Ugradar, Heike Elflein, Katharina A Ponto, Mario Salvi

Ophthalmology· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapy With Different Dose Regimens of Rituximab in Patients With Active Moderate-To-Severe Graves' Orbitopathy.
Irene Campi, Guia Vannucchi, Ilaria Muller, Elisa Lazzaroni, Nicola Currò, Mario Salvi

Front Endocrinol (Lausanne)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy Profile and Safety of Very Low-Dose Rituximab in Patients with Graves' Orbitopathy.
Guia Vannucchi, Irene Campi, Danila Covelli, Nicola Currò, Elisa Lazzaroni, Mario Salvi

Thyroid· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification of Global Ocular Motility Impairment in Graves' Orbitopathy by Measuring Eye Muscle Ductions.
Irene Campi, Nicola Currò, Guia Vannucchi, Danila Covelli, Simona Simonetta, Mario Salvi

Thyroid· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2-related atypical thyroiditis.
Ilaria Muller, Daniele Cannavaro, Davide Dazzi, Danila Covelli, Giovanna Mantovani, Mario Salvi

Lancet Diabetes Endocrinol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Teprotumumab for the Treatment of Active Thyroid Eye Disease.
Raymond S Douglas, George J Kahaly, Amy Patel, Saba Sile, Elizabeth H Z Thompson, Mario Salvi

N Engl J Med· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of Orbitopathy by Oral or Intravenous Steroid Prophylaxis in Short Duration Graves' Disease Patients Undergoing Radioiodine Ablation: A Prospective Randomized Control Trial Study.
Guia Vannucchi, Danila Covelli, Irene Campi, Nicola Currò, Davide Dazzi, Mario Salvi

Thyroid· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined immunosuppressants and less steroids in active graves' orbitopathy?
Mario Salvi, Danila Covelli

Clin Endocrinol (Oxf)· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B cells in Graves' Orbitopathy: more than just a source of antibodies?
Mario Salvi, Danila Covelli

Eye (Lond)· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Step-down steroid-sparing therapy in active thyroid eye disease.
Mario Salvi

Nat Rev Endocrinol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tocilizumab for thyroid eye disease.
Shirin Hamed Azzam, Swan Kang, Mario Salvi, Daniel G Ezra

Cochrane Database Syst Rev· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining micro-RNA and protein sequencing to detect robust biomarkers for Graves' disease and orbitopathy.
Lei Zhang, Giulia Masetti, Giuseppe Colucci, Mario Salvi, Danila Covelli

Sci Rep· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis